Advertisement
Advertisement
RMD
ResMed Inc.
213.81
USDSponsored
+1.88
+0.89%
Apr 30, 16:00 UTC -4
Closed
After-Market
211.75
-2.06
-0.96%
RMD Earnings Reports
Positive Surprise Ratio
RMD beat 28 of 41 last estimates.
68%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q4 26 (Revenue/ EPS)
$1.48B
/$2.91
Implied change from Q3 26 (Revenue/ EPS)
+3.07%
/+1.75%
Implied change from Q4 25 (Revenue/ EPS)
+9.45%
/+14.57%
ResMed Inc. earnings per share and revenue
On Apr 30, 2026, RMD reported earnings of 2.86 USD per share (EPS) for Q3 26, beating the estimate of 2.82 USD, resulting in a 1.20% surprise. Revenue reached 1.43 billion, compared to an expected 1.43 billion, with a -0.14% difference.
Looking ahead to Q4 26, 17 analysts forecast an EPS of 2.91 USD, with revenue projected to reach 1.48 billion USD, implying an increase of 1.75% EPS, and increase of 3.07% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Abbott Laboratories
Report Date
Apr 16, 2026 For Q1 26
Estimate
$1.15
Actual
$1.14
Surprise
-0.45%
Stryker Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$3.01
Actual
$2.60
Surprise
-13.75%
Boston Scientific Corp.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.79
Actual
$0.80
Surprise
+0.69%
GE HealthCare Technologies Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
$1.07
Actual
$0.99
Surprise
-7.55%
Zimmer Biomet Holdings, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$1.88
Actual
$2.09
Surprise
+10.99%
Baxter International Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.31
Actual
$0.36
Surprise
+15.72%
Bio-Rad Laboratories, Inc.Class A
Report Date
Apr 30, 2026 For Q1 26
Estimate
$2.00
Actual
$1.89
Surprise
-5.68%
Cerus Corp
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.01
Surprise
+75.49%
FAQ
What were ResMed Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, ResMed Inc. reported EPS of $2.86, beating estimates by 1.2%, and revenue of $1.43B, -0.14% below expectations.
How did the market react to ResMed Inc.'s Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is ResMed Inc. expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for ResMed Inc.'s next earnings report?
Based on 17
analysts, ResMed Inc. is expected to report EPS of $2.91 and revenue of $1.48B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement